VivoSim Labs, Inc.
VIVS
$2.24
$0.052.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -24.32% | -27.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -24.32% | -27.45% | |||
| Cost of Revenue | -7.79% | 16.53% | |||
| Gross Profit | 7.16% | -19.31% | |||
| SG&A Expenses | -10.81% | -16.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.79% | -7.89% | |||
| Operating Income | 9.61% | 7.58% | |||
| Income Before Tax | 10.55% | -141.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.48% | -141.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.48% | -141.49% | |||
| EBIT | 9.61% | 7.58% | |||
| EBITDA | 9.74% | 7.73% | |||
| EPS Basic | 13.96% | -126.95% | |||
| Normalized Basic EPS | 14.03% | 41.34% | |||
| EPS Diluted | 13.96% | -126.95% | |||
| Normalized Diluted EPS | 14.03% | 41.34% | |||
| Average Basic Shares Outstanding | 4.05% | 53.96% | |||
| Average Diluted Shares Outstanding | 4.05% | 53.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||